• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用荧光标记双链寡核苷酸的拓扑异构酶II DNA切割分析

Topoisomerase II DNA Cleavage Assay Using Fluorescently Labelled Double-Stranded Oligonucleotides.

作者信息

Cowell Ian G, Ling Elise M, Austin Caroline A

机构信息

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Methods Mol Biol. 2025;2928:97-108. doi: 10.1007/978-1-0716-4550-5_9.

DOI:10.1007/978-1-0716-4550-5_9
PMID:40372640
Abstract

DNA topoisomerase II (TOP2) regulates DNA topological states including supercoiling and knotting via a strand-passage reaction that involves transiently breaking and rejoining both strands of the DNA. These enzymes are the targets of a category of drugs termed topoisomerase poisons, which block the rejoining reaction, leading to DNA cleavage. In vitro DNA cleavage assays have been very useful in studying various properties of TOP2, including cleavage site preferences and the effects of TOP2 amino acid substitutions or reaction conditions on DNA cleavage. These assays employ purified or recombinant TOP2 in the presence or absence of TOP2 poisons, followed by electrophoretic separation of DNA cleavage products. The substrates for these assays have typically been radioactively end-labelled DNA fragments. Here, we describe an alternative method employing fluorescently labelled oligonucleotide substrates, combined with convenient mini-gel electrophoretic separation. This methodology combines stable, long-lived substrates with an easily used gel system and convenient imaging and quantification.

摘要

DNA拓扑异构酶II(TOP2)通过链通过反应调节DNA拓扑状态,包括超螺旋和打结,该反应涉及DNA两条链的瞬时断裂和重新连接。这些酶是一类称为拓扑异构酶毒物的药物的作用靶点,这些药物会阻断重新连接反应,导致DNA裂解。体外DNA裂解试验在研究TOP2的各种特性方面非常有用,包括裂解位点偏好以及TOP2氨基酸取代或反应条件对DNA裂解的影响。这些试验在有或没有TOP2毒物的情况下使用纯化的或重组的TOP2,然后对DNA裂解产物进行电泳分离。这些试验的底物通常是放射性末端标记的DNA片段。在这里,我们描述了一种替代方法,该方法使用荧光标记的寡核苷酸底物,并结合方便的微型凝胶电泳分离。这种方法将稳定、寿命长的底物与易于使用的凝胶系统以及方便的成像和定量相结合。

相似文献

1
Topoisomerase II DNA Cleavage Assay Using Fluorescently Labelled Double-Stranded Oligonucleotides.使用荧光标记双链寡核苷酸的拓扑异构酶II DNA切割分析
Methods Mol Biol. 2025;2928:97-108. doi: 10.1007/978-1-0716-4550-5_9.
2
Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.抑制蛋白酶体介导的拓扑异构酶 II-DNA 蛋白复合物的加工可保持基因组完整性。
Elife. 2020 Feb 14;9:e53447. doi: 10.7554/eLife.53447.
3
Measurement of Drug-Stabilized Topoisomerase II Cleavage Complexes by Flow Cytometry.通过流式细胞术测量药物稳定的拓扑异构酶II切割复合物
Curr Protoc Cytom. 2017 Jul 5;81:7.48.1-7.48.8. doi: 10.1002/cpcy.21.
4
Atp-bound topoisomerase ii as a target for antitumor drugs.与三磷酸腺苷(ATP)结合的拓扑异构酶II作为抗肿瘤药物的靶点。
J Biol Chem. 2001 May 11;276(19):15990-5. doi: 10.1074/jbc.M011143200. Epub 2001 Feb 23.
5
Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.
FASEB J. 2000 Nov;14(14):2339-44. doi: 10.1096/fj.00-0089com.
6
Single-molecule Förster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents.单分子荧光共振能量转移(FRET)分析揭示了在存在靶向TOP2的试剂的情况下DNA拓扑异构酶II(Top2)相互作用的动力学。
J Biol Chem. 2017 Jul 28;292(30):12589-12598. doi: 10.1074/jbc.M117.792861. Epub 2017 Jun 19.
7
Isolation and characterization of mAMSA-hypersensitive mutants. Cytotoxicity of Top2 covalent complexes containing DNA single strand breaks.mAMSA超敏突变体的分离与鉴定。含DNA单链断裂的Top2共价复合物的细胞毒性。
J Biol Chem. 2008 Oct 24;283(43):29239-50. doi: 10.1074/jbc.M804058200. Epub 2008 Aug 22.
8
Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.拓扑异构酶 2 DNA-蛋白交联物的解析的分子机制。
Cell Mol Life Sci. 2020 Jan;77(1):81-91. doi: 10.1007/s00018-019-03367-z. Epub 2019 Nov 15.
9
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.嵌入型 TOP2 毒物在较高浓度时会减弱拓扑异构酶的作用。
Mol Pharmacol. 2019 Oct;96(4):475-484. doi: 10.1124/mol.119.117259. Epub 2019 Aug 9.
10
Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy.泛素化和 SUMO 化调控拓扑异构酶 II 的稳定性和活性:癌症化疗的临床意义。
Mol Biol Rep. 2021 Sep;48(9):6589-6601. doi: 10.1007/s11033-021-06665-7. Epub 2021 Sep 2.

本文引用的文献

1
DNA fragility at the / locus: insights from old and new technologies./ 位点的 DNA 脆弱性:新旧技术的启示。
Open Biol. 2023 Jan;13(1):220232. doi: 10.1098/rsob.220232. Epub 2023 Jan 11.
2
High-efficiency recombinant protein purification using mCherry and YFP nanobody affinity matrices.使用 mCherry 和 YFP 纳米抗体亲和基质进行高效重组蛋白纯化。
Protein Sci. 2022 Sep;31(9):e4383. doi: 10.1002/pro.4383.
3
Human topoisomerases and their roles in genome stability and organization.人类拓扑异构酶及其在基因组稳定性和组织中的作用。
Nat Rev Mol Cell Biol. 2022 Jun;23(6):407-427. doi: 10.1038/s41580-022-00452-3. Epub 2022 Feb 28.
4
Selectable high-yield recombinant protein production in human cells using a GFP/YFP nanobody affinity support.使用 GFP/YFP 纳米抗体亲和支架在人细胞中进行可选择的高产量重组蛋白生产。
Protein Sci. 2018 Jun;27(6):1083-1092. doi: 10.1002/pro.3409. Epub 2018 Apr 17.
5
The MLL recombinome of acute leukemias in 2013.2013 年急性白血病的 MLL 重排组。
Leukemia. 2013 Nov;27(11):2165-76. doi: 10.1038/leu.2013.135. Epub 2013 Apr 30.
6
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.涉及拓扑异构酶 IIβ介导的 DNA 链断裂和基因邻近性的治疗相关白血病中 MLL 易位的模型。
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8989-94. doi: 10.1073/pnas.1204406109. Epub 2012 May 21.
7
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.对米托蒽醌耐药的人类拓扑异构酶IIβ突变体G465D的ATP水解活性降低。
Nucleic Acids Res. 2006 Mar 20;34(5):1597-607. doi: 10.1093/nar/gkl057. Print 2006.
8
Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance.人类DNA拓扑异构酶IIβ中的P732L突变在有钙存在的情况下消除了DNA切割,并赋予耐药性。
Mol Pharmacol. 2006 Jan;69(1):130-9. doi: 10.1124/mol.105.015933. Epub 2005 Oct 20.
9
Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide.人类DNA拓扑异构酶IIβ中的E522K突变赋予了对盐酸N-(4'-(9-吖啶基氨基)-苯基)氨基甲酸甲酯和N-(4'-(9-吖啶基氨基)-3-甲氧基-苯基)甲烷磺酰胺的抗性,但对依托泊苷敏感。
Mol Pharmacol. 2004 Sep;66(3):430-9. doi: 10.1124/mol.66.3..
10
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.在MLL和AF-9基因中,5'-TATTA-3'序列处的相互DNA拓扑异构酶II切割事件产生同源单链突出端,这些突出端退火形成治疗相关急性髓系白血病中的der(11)和der(9)基因组断点连接,无需进一步加工。
Oncogene. 2003 Nov 20;22(52):8448-59. doi: 10.1038/sj.onc.1207052.